A new executive order signed in the Oval Office is quickly drawing national attention — and sparking intense debate across the country.
Donald Trump has directed federal agencies to end support for certain medical treatments for minors, including procedures related to gender transition. The order focuses on federal funding and policies tied to these treatments.
Under the directive, agencies have been instructed to stop backing procedures such as surgeries, puberty blockers, and hormone treatments for individuals under 18 through federal health programs.
The order also calls for a review of medical providers involved in these treatments, including the possibility of further action related to licensing and oversight.
Supporters of the move argue that minors may not be able to fully understand or consent to long-term medical decisions, especially those that could have lasting effects.
Critics, however, say the order could interfere with decisions made between families and medical professionals, as well as conflict with existing medical guidelines that support individualized care.
Before this federal action, more than 20 states had already introduced or passed their own restrictions related to these treatments.
The policy is now facing legal challenges in multiple federal courts, setting up what could become a major legal battle in the months ahead.
